Teva Pharmaceuticals USA recalls Moexipril Hydrochloride and Hydrocholorothiazide Tablets USP, 7.5 mg/12.5 mg, 100-count bottle, Rx only, Distributed
Teva recalls 7.5mg/12.5mg Moexipril-Hydrochlorothiazide tablets due to high impurity levels detected in stability testing. This may pose a risk to patients using prescription medication.
Recall notice
Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.
Contact the company & request your remedy
What happened, in plain English
Teva Pharmaceuticals is recalling a specific prescription tablet combination because testing found high levels of an impurity that could be harmful. This recall affects patients who have been prescribed this medication and may require medical evaluation. Read more at govinfonow.com/recall/41018-teva-moexipril-hydrochlorothiazide-tablets-recall-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/41018-teva-moexipril-hydrochlorothiazide-tablets-recall-impurity-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0208-2018
Cite this page
“Teva Moexipril-Hydrochlorothiazide Tablets Recall: Impurity Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41018-teva-moexipril-hydrochlorothiazide-tablets-recall-impurity-risk. Based on FDA recall #D-0208-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0208-2018%22&limit=1).
Why it’s dangerous
Routine stability testing detected unusually high levels of a chemical impurity called Moexipril Diketopiperazine. This impurity could potentially cause harm to patients taking the medication, though the exact risk level isn't specified in the recall notice.
Who’s affected
Patients prescribed this specific combination of Moexipril and Hydrochlorothiazide tablets. Those with kidney issues or on blood pressure medication may be at higher risk.
How to tell if you have this one
Check for the 100-count bottle labeled 'Moexipril Hydrochloride and Hydrochlorothiazide Tablets USP, 7.5 mg/12.5 mg'. The product was distributed by Teva Pharmaceuticals USA with NDC 0093-5213-01 and lot number 30229439A, expiring December 2017.
- Brand
Teva Pharmaceuticals- Category
Drug
What to do — step by step
Check Medication Details
Identify if you have the 100-count bottle with NDC 0093-5213-01 and lot number 30229439A.
Questions people ask
Is this medication safe to take?
The recall notice states that testing found high levels of an impurity, but does not specify if the medication is safe to take. Patients should consult their healthcare provider.
How can I check if I have the recalled product?
Look for the 100-count bottle labeled 'Moexipril Hydrochloride and Hydrochlorothiazide Tablets USP, 7.5 mg/12.5 mg' with NDC 0093-5213-01 and lot number 30229439A.
What should I do if I have this medication?
The recall notice does not specify a remedy, so patients should contact their healthcare provider for guidance.
Contact Teva Pharmaceuticals
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0208-2018 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-0208-2018 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0208-2018 (December 14, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0208-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.